Director/PDMR Shareholding
1 August 2022 17:00 BST Revised stock exchange announcement due to a formatting issue with the original announcement published at 1505 today, 1 August 2022. There have been no changes to the underlying information within the release. Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that on 29 July 2022 awards of AstraZeneca American Depositary Shares (ADSs) vested to Dr Aradhana Sarin, Executive Director and Chief Financial Officer. Each ADS represents one half of an Ordinary Share of $0.25 in the Company. In accordance with